2seventy bio, Inc.
TSVT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $37,862 | $100,387 | $91,496 | $54,522 |
| % Growth | -62.3% | 9.7% | 67.8% | – |
| Cost of Goods Sold | $22,563 | $16,918 | $26,219 | $12,588 |
| Gross Profit | $15,299 | $83,469 | $65,277 | $41,934 |
| % Margin | 40.4% | 83.1% | 71.3% | 76.9% |
| R&D Expenses | $76,917 | $230,758 | $248,735 | $261,937 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $43,924 | $69,414 | $79,450 | $93,506 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $9,888 | $20,905 | $0 | $0 |
| Operating Expenses | $130,729 | $321,077 | $328,185 | $355,443 |
| Operating Income | -$115,430 | -$237,608 | -$262,908 | -$313,509 |
| % Margin | -304.9% | -236.7% | -287.3% | -575% |
| Other Income/Exp. Net | $58,183 | $20,038 | $8,755 | $21,296 |
| Pre-Tax Income | -$57,247 | -$217,570 | -$254,153 | -$292,213 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$57,247 | -$217,570 | -$254,144 | -$276,214 |
| % Margin | -151.2% | -216.7% | -277.8% | -506.6% |
| EPS | -1.1 | -4.42 | -7.13 | -11.71 |
| % Growth | 75.1% | 38% | 39.1% | – |
| EPS Diluted | -1.1 | -4.42 | -7.13 | -11.71 |
| Weighted Avg Shares Out | 52,218 | 49,276 | 35,637 | 23,585 |
| Weighted Avg Shares Out Dil | 52,218 | 49,276 | 35,637 | 23,585 |
| Supplemental Information | – | – | – | – |
| Interest Income | $10,875 | $12,413 | $2,932 | $88 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $7,096 | $10,285 | $11,533 | $16,400 |
| EBITDA | -$98,446 | -$206,418 | -$251,375 | -$297,159 |
| % Margin | -260% | -205.6% | -274.7% | -545% |